Using credit data to detect early signs of Alzheimer's disease.
Using Digital Signals from Credit Data for Early Detection of Alzheimer's Disease and Related Dementias
This study is looking at how changes in people's credit and financial habits might help spot early signs of Alzheimer's and related dementias before any memory problems show up, so we can find ways to help those at risk sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11015798 on NIH RePORTER |
What this research studies
This research investigates how digital signals from credit data can be utilized to identify individuals at risk for Alzheimer's disease and related dementias (ADRD) before cognitive symptoms become apparent. By analyzing a large database of credit information merged with Medicare data, the study aims to develop machine learning algorithms that can detect early financial declines associated with ADRD. This approach seeks to create a new screening tool that could facilitate earlier diagnosis and intervention for those at risk. The research leverages existing data to provide insights into the financial behaviors that may indicate the onset of dementia.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who may be at risk for Alzheimer's disease or related dementias.
Not a fit: Patients who are already diagnosed with advanced stages of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of Alzheimer's disease, allowing for timely interventions that may improve patient outcomes.
How similar studies have performed: Previous research has shown promise in using financial data to identify early signs of cognitive decline, suggesting that this approach may be effective.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Gresenz, Carole R — Georgetown University
- Study coordinator: Gresenz, Carole R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.